Yazar "Uygur, Dilek" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe The effect of long interpregnancy interval on labor characteristics and pregnancy outcomes: A tertiary maternity hospital experience(DRUNPP-SARAJEVO, 2012) Dogan, Nasuh Utku; Cicek, Mahmut Nedim; Uygur, Dilek; Dogan, Selen; Erol, NidaObjective: We evaluated effect of long interpregnancy intervals (IPI) on the length of labor and perinatal outcomes. Materials and methods: In this retrospective study, 249 women with uncomplicated vaginal delivery were divided into three groups (Nulliparous women was first group, multiparous women with IPI shorter than 3 years second group and women with IPI longer than 6 years the last group). Results: Nulliparous women had longer total delivery time than multiparous women (p< 0.01). But admission to NICU (p = 0.30) and meconium stain rates (p= 0.74) were similar. Total delivery time meconium stain and NICU admission rates for multiparous women in short IPI group (<3 years) were similar to women with a longer IPI (> 6 years). But more women in longer IPI group needed oxytocin augmention (p=0.031). Conclusion: Multiparous women with prolonged IPI might be evaluated in the same way as women with shorter IPIs with favorable perinatal outcomes. But obstetrician should be more cautious with the potential risks of labor augmentation with oxytocin in this group of patients.Öğe Effect of Strontium Ranelate on Serum Leptin and Bone Turnover Markers in Women with Established Postmenopausal Osteoporosis(SCI PRINTERS & PUBL INC, 2013) Bayhan, Ilhan; Dogan, Nasuh U.; Ozaksit, Gulnur; Uygur, Dilek; Ugurlu, Nil; Ugur, MustafaOBJECTIVE: To assess the ass. ociation between leptin levels and bone mineral density (BMD) and bone metabolism markers in postmenopausal women taking strontium ranelate. STUDY DESIGN: In this longitudinal uncontrolled study, postmenopausal osteoporotic women were administered strontium ranelate and categorized into 1 of 2 groups: overweight and lean. BMD, serum leptin, bone -specific alkaline phosphatase (ALP) and urinary deoxypyridinoline (Dpd) were assessed at baseline, 6 and 12 months of the therapy. RESULTS: For all 47 women, leptin levels increased at the sixth month (p =0.001) and 1 year after treatment (p = 0.001), Dpd levels. decreased at the sixth month.(p = 0.001) and 1 year after treatment (p =0.003), but ALP levels did not change with respect to basal levels. Spine and hip BMD also increased at the end of 1 year (p =0.01 and p =0.001, respectively). For overweight women leptin levels increased 6 months and 1 year after treatment (p =0.003 and p =0.001, respectively). Dpd levels decreased significantly at the sixth month and at 1 year (p =0.001 and p = 0.041), but ALP levels did not change. Hip and spine BMD also increased (p =0.036 and p =0.002). The lean group had similar serum results and BMD scores after treatment. CONCLUSION: Our data supports a positive effect of leptin on bone metabolism in favor of bone resorption inhibition in postmenopausal osteoporotic women on strontium treatment.